Introduction Updated estimates of the US Alzheimer's disease (AD) population, including
under‐represented populations, are needed to improve clinical trial diversity. Methods A …

The risk of Alzheimer disease (AD) increases with age, family history and informative genetic
variants. Sadly, there is still no cure or means of prevention. As in other complex diseases …

Alzheimer's disease (AD) has no cure, but early detection and risk prediction could allow
earlier intervention. Genetic risk factors may differ between ethnic populations. To discover …

The poor generalizability of clinical research data due to the enrollment of highly educated,
non‐Latinx White participants hampers the development of therapies for Alzheimer's …

Importance Compared with non-Hispanic White individuals, African American individuals
from the same community are approximately twice as likely to develop Alzheimer disease …

Alzheimer's Disease (AD) is a common disorder of the elderly that is both highly heritable
and genetically heterogeneous. Here, we investigated the association between AD and both …

Abstract Introduction The Alzheimer's Disease Prevention Registry (ADPR) of the Joseph
and Kathleen Bryan Alzheimer's Disease Research Center at Duke University has been …

Importance Polygenic risk scores (PRSs), which aggregate the genetic effects of single-
nucleotide variants identified in genome-wide association studies (GWASs), can help …

INTRODUCTION: Despite a two-fold increased risk, individuals of African ancestry have
been significantly underrepresented in Alzheimers Disease (AD) genomics efforts …

Abstract Background The ADSP‐FUS is a National Institute on Aging (NIA) initiative focused
on identifying genetic risk and protective variants for late‐onset Alzheimer Disease (LOAD) …